These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15628908)

  • 1. Results of a survey of hospital coagulation laboratories in the United States, 2001.
    Shahangian S; Stanković AK; Lubin IM; Handsfield JH; White MD
    Arch Pathol Lab Med; 2005 Jan; 129(1):47-60. PubMed ID: 15628908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Lloyd J; Street A; Marsden K;
    Pathology; 2005 Jun; 37(3):234-8. PubMed ID: 16175898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations.
    Marlar RA; Clement B; Gausman J
    Semin Thromb Hemost; 2017 Apr; 43(3):253-260. PubMed ID: 27272964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study.
    Samuel S; Allison TA; Sharaf S; Yau G; Ranjbar G; Mckaig N; Nguyen A; Escobar M; Choi HA
    J Clin Pharm Ther; 2016 Oct; 41(5):499-502. PubMed ID: 27381025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy.
    McLaughlin K; Rimsans J; Sylvester KW; Fanikos J; Dorfman DM; Senna P; Connors JM; Goldhaber SZ
    Clin Appl Thromb Hemost; 2019; 25():1076029619876030. PubMed ID: 31530176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of aPTT reporting in Canadian medical laboratories. The need for increased standardization. Thrombosis Interest Group of Canada.
    Brigden ML; Johnston M
    Am J Clin Pathol; 2000 Aug; 114(2):276-82. PubMed ID: 10941344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of coagulation laboratory practice in Thailand: the first step to establish a National External Quality Assessment Scheme (NEQAS) for blood coagulation.
    Tientadakul P; Opartkiattikul N; Wongtiraporn W
    J Med Assoc Thai; 2007 Dec; 90(12):2616-23. PubMed ID: 18386711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Assessment of the State of Current Practice in Coagulation Laboratories.
    Zantek ND; Hayward CP; Simcox TG; Smock KJ; Hsu P; Van Cott EM
    Am J Clin Pathol; 2016 Sep; 146(3):378-83. PubMed ID: 27510716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of unfractionated heparin protocols using antifactor Xa monitoring or activated partial thrombin time monitoring.
    Frugé KS; Lee YR
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S90-7. PubMed ID: 26272899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of coagulation laboratory practice in Thailand: the first-year experience of the national external quality assessment scheme for blood coagulation.
    Tientadakul P; Opartkiattikul N; Wongtiraporn W
    Arch Pathol Lab Med; 2009 Jan; 133(1):72-7. PubMed ID: 19123740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.
    Yim JM; Albers GW; Vlasses PH
    Ann Pharmacother; 1996 Dec; 30(12):1390-5. PubMed ID: 8968449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions.
    Bürki S; Brand B; Escher R; Wuillemin WA; Nagler M
    BMJ Open; 2018 Jun; 8(6):e022943. PubMed ID: 29886450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
    Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
    Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P; Ajzenberg N; Smahi M; Guillin MC
    Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW; Vondracek TG
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems in laboratory monitoring of heparin dosage.
    Kitchen S
    Br J Haematol; 2000 Nov; 111(2):397-406. PubMed ID: 11122078
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association.
    Pai M; Moffat KA; Plumhoff E; Hayward CP
    Am J Clin Pathol; 2011 Dec; 136(6):836-41. PubMed ID: 22095367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.